-
Deine Einschätzung
Was spricht für und gegen Advanced Proteome Therapeutics in den nächsten Jahren?
Pro
Kontra
Rendite von Advanced Proteome Therapeutics im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
Satellos Bioscience Inc. | -6,79 % | 28,64 % | 35,90 % | 48,88 % | -5,36 % | 110,32 % | - |
Vaxart Inc. | 4,37 % | -6,00 % | 1,51 % | -61,05 % | -58,16 % | -85,86 % | -95,14 % |
Larimar Therapeutics Inc. | 0,50 % | 47,41 % | 19,88 % | -30,78 % | 6,99 % | 18,45 % | -67,16 % |
News

Meet the Low-Cost Vanguard ETF That Has 20% of Its Holdings in Nvidia, Broadcom, and AMD
Megacap technology stocks are starting to look a little expensive, especially after recent moves in stocks like Nvidia (NASDAQ: NVDA) and Advanced Micro Devices (NASDAQ: AMD). It's tough to know

This Artificial Intelligence (AI) Stock Is Quietly Outperforming Nvidia in 2025
Nvidia is arguably the king of Wall Street these days. As the maker of high-performing graphics processing units (GPUs) that power artificial intelligence (AI) programs and large language models

Marvell Insiders Buy Shares—Should Investors Follow Suit?
Marvell Technology (NASDAQ: MRVL) insiders are purchasing shares, and there are compelling reasons for investors to take notice. The company is well-positioned to benefit from the growth and